116 related articles for article (PubMed ID: 3785587)
1. A behavioral pharmacological study on CCK-8 related peptides in mice.
Moroji T; Hagino Y
Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
[TBL] [Abstract][Full Text] [Related]
2. Bilateral subdiaphragmatic vagotomy does not prevent the behavioral effects of systematically administered ceruletide in mice.
Moroji T; Hagino Y
Neuropeptides; 1987 Apr; 9(3):217-24. PubMed ID: 3601011
[TBL] [Abstract][Full Text] [Related]
3. A behavioural pharmacological study on intracerebroventricularly administered CCK-8 related peptides in mice.
Hagino Y; Moroji T; Iizuka R
Neuropeptides; 1989; 13(2):107-13. PubMed ID: 2739882
[TBL] [Abstract][Full Text] [Related]
4. Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice.
Zetler G
Neuropharmacology; 1985 Mar; 24(3):251-9. PubMed ID: 2859544
[TBL] [Abstract][Full Text] [Related]
5. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
Van Ree JM; Gaffori O; De Wied D
Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
Zetler G
Eur J Pharmacol; 1983 Oct; 94(3-4):261-70. PubMed ID: 6140174
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of ceruletide in the vertical and horizontal locomotor activities of mice.
Itoh T; Murai S; Masuda Y; Abe E; Ohkubo N; Itsukaichi O; Shoji S
Pharmacol Biochem Behav; 1992 Oct; 43(2):571-6. PubMed ID: 1438494
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine evaluation of CCK-peptides on dopaminergic function in man.
Lal S; Nair NP; Eugenio H; Thavundayil J; Lizondo E; Wood PL; Etienne P; Guyda H
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):537-44. PubMed ID: 6320299
[TBL] [Abstract][Full Text] [Related]
9. Apomorphine separates the antinociceptive effects of cholecystokinin octapeptide and ceruletide from those of morphine.
Zetler G
Eur J Pharmacol; 1983 Aug; 92(1-2):151-4. PubMed ID: 6313385
[TBL] [Abstract][Full Text] [Related]
10. Central effects of ceruletide analogues.
Zetler G
Peptides; 1981; 2 Suppl 2():65-9. PubMed ID: 6283499
[TBL] [Abstract][Full Text] [Related]
11. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
Crawley JH
Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of cholecystokinin and its related peptides in rats.
Itoh S; Katsuura G
Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
[TBL] [Abstract][Full Text] [Related]
13. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
Vasar E; Harro J; Lang A; Pôld A; Soosaar A
Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
[TBL] [Abstract][Full Text] [Related]
14. Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
Zetler G
Eur J Pharmacol; 1984 Jul; 102(2):333-40. PubMed ID: 6090162
[TBL] [Abstract][Full Text] [Related]
15. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
Kovács GL; Szabó G; Penke B; Telegdy G
Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
Kihara T; Ikeda M; Matsubara K; Matsushita A
Eur J Pharmacol; 1993 Jan; 230(3):271-7. PubMed ID: 8440305
[TBL] [Abstract][Full Text] [Related]
17. Clonidine sensitizes mice for apomorphine-induced stereotypic gnawing: antagonism by neuroleptics and cholecystokinin-like peptides.
Zetler G
Eur J Pharmacol; 1985 May; 111(3):309-18. PubMed ID: 2862047
[TBL] [Abstract][Full Text] [Related]
18. Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
Hsiao S; Katsuura G; Itoh S
Behav Neurosci; 1985 Oct; 99(5):853-60. PubMed ID: 3939625
[TBL] [Abstract][Full Text] [Related]
19. Ceruletide acts in the abdomen, not in the brain, to produce satiety.
Smith GP; Jerome C; Kulkosky P; Simansky KJ
Peptides; 1984; 5(6):1149-57. PubMed ID: 6099563
[TBL] [Abstract][Full Text] [Related]
20. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
Katsuura G; Itoh S
Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
